Sugi Predict

Sugi Predict / Compounds / SCHEMBL1608655

SCHEMBL1608655

SCHEMBL1608655

CC(Oc1ccc(Cl)cc1F)n1ccc2ccc(C(=O)NO)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 11/20 0.43
▸ HDAC6 Q9UBN7 7/20 0.43
▸ HDAC1 Q13547 6/20 0.43
▸ HDAC11 Q96DB2 2/20 0.43
▸ HDAC3 O15379 1/20 0.43
▸ HDAC4 P56524 1/20 0.43
▸ HDAC7 Q8WUI4 1/20 0.43
▸ HDAC2 Q92769 1/20 0.43
▸ HDAC10 Q969S8 1/20 0.43
▸ HDAC9 Q9UKV0 1/20 0.43
▸ HDAC5 Q9UQL6 1/20 0.43
▸ NCOR2 Q9Y618 1/20 0.43
▸ KCNQ3 O43525 1/20 0.40
▸ KCNQ2 O43526 1/20 0.40
▸ PPARG P37231 5/20 0.40
▸ PPARA Q07869 5/20 0.40
▸ CPT1A P50416 1/20 0.37
▸ CPT1B Q92523 1/20 0.37
▸ MAPK11 Q15759 1/20 0.37
▸ MAPK14 Q16539 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1608695 0.89 HDAC6 (0.42) HDAC8HDAC6HDAC1HDAC11HDAC3
SCHEMBL1608628 0.86 NR3C2 (0.44) HDAC8HDAC6HDAC1HDAC11HDAC3
SCHEMBL1608825 0.84 HDAC6 (0.48) HDAC8HDAC6HDAC1HDAC11HDAC3
SCHEMBL1607720 0.83 HDAC6 (0.48) HDAC8HDAC6HDAC1HDAC11HDAC3
SCHEMBL1609232 0.82 HDAC6 (0.41) HDAC8HDAC6HDAC1HDAC11HDAC3
SCHEMBL1607716 0.82 HDAC6 (0.48) HDAC8HDAC6HDAC1HDAC11HDAC3
SCHEMBL1608657 0.76 HDAC8 (0.49) HDAC8HDAC6HDAC1HDAC11HDAC3
SCHEMBL1608595 0.76 HDAC6 (0.46) HDAC8HDAC6HDAC1HDAC11HDAC3
SCHEMBL1607784 0.74 HDAC6 (0.47) HDAC8HDAC6HDAC1HDAC11HDAC3
SCHEMBL1607723 0.74 HDAC6 (0.41) HDAC8HDAC6HDAC1HDAC11HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150320758-A1 SELECTIVE INHIBITORS OF HISTONE DEACTYLASE PHARMACYCLICS LLC 2015-11-12 — — US disclosed
US-8906954-B2 Selective inhibitors of histone deacetylase PHARMACYCLICS, INC. (US) 2014-12-09 — — US disclosed
US-20140004174-A1 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2014-01-02 — — US disclosed
US-8466193-B2 Selective inhibitors of histone deacetylase PHARMACYCLICS, INC. (US) 2013-06-18 — — US disclosed
US-20110081409-A1 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS LLC 2011-04-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110081409-A1 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE HDAC8, HDAC1, HDAC11 HDAC8 1/4885HDAC6 11/4885HDAC1 2/4885
US-20150320758-A1 SELECTIVE INHIBITORS OF HISTONE DEACTYLASE HDAC8, HDAC1, HDAC5 HDAC8 1/4885HDAC6 11/4885HDAC1 2/4885
US-20140004174-A1 SELECTIVE INHIBITORS OF HISTONE DEACETYLASE HDAC8, HDAC1, HDAC11 HDAC8 1/4885HDAC6 11/4885HDAC1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.